ICU Medical Inc (ICUI) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.
Total Assets Chart for ICU Medical Inc
ICU Medical Inc (ICUI) total assets for FY2025 were USD 4.1B, a -3.6% change from FY2024. ICU Medical Inc's total assets grew from USD 4.3M in 1991 to USD 4.1B in 2025 (94097.9% over 34 years). Total assets compound annual growth rate: 5-year CAGR of 18.1%, 10-year CAGR of 20.5%, 20-year CAGR of 16.1%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $4.08B
- Implied Share Price
- $162.99
- Enterprise Value
- $5.00B
- Revenue (TTM)
- $2.16B
- EBITDA
- $326.12M
- Profit Margin
- 1.39%
- Trailing P/E
- 136.97
- Forward P/E
- 16.95
- Price/Book (MRQ)
- 1.87
- Price/Sales (TTM)
- 1.89
- EV/EBITDA
- 17.59
- EV/Revenue
- 2.31
- Dividend Yield
- —
- Book Value
- $86.05
- Free Cash Flow (FY2025)
- $91.80M
- Free Cash Flow Yield
- 2.25%
Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.